QS Investors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $463K | Hold |
10,500
| – | – | 0.01% | 769 |
|
|
2021
Q1 | $518K | Sell |
10,500
-200
| -2% | -$9.87K | 0.01% | 787 |
|
|
2020
Q4 | $450K | Hold |
10,700
| – | – | 0.01% | 834 |
|
|
2020
Q3 | $490K | Sell |
10,700
-35,660
| -77% | -$1.63M | 0.01% | 701 |
|
|
2020
Q2 | $2.33M | Buy |
46,360
+2,200
| +5% | +$110K | 0.03% | 427 |
|
|
2020
Q1 | $2.27M | Hold |
44,160
| – | – | 0.04% | 374 |
|
|
2019
Q4 | $2.74M | Sell |
44,160
-680
| -2% | -$42.2K | 0.03% | 481 |
|
|
2019
Q3 | $2.69M | Hold |
44,840
| – | – | 0.03% | 459 |
|
|
2019
Q2 | $3.78M | Sell |
44,840
-781
| -2% | -$65.9K | 0.04% | 355 |
|
|
2019
Q1 | $4.36M | Sell |
45,621
-25,493
| -36% | -$2.44M | 0.05% | 312 |
|
|
2018
Q4 | $5.04M | Hold |
71,114
| – | – | 0.06% | 214 |
|
|
2018
Q3 | $6.08M | Buy |
71,114
+100
| +0.1% | +$8.55K | 0.06% | 223 |
|
|
2018
Q2 | $8.23M | Sell |
71,014
-300
| -0.4% | -$34.8K | 0.08% | 164 |
|
|
2018
Q1 | $5.77M | Sell |
71,314
-4,390
| -6% | -$355K | 0.06% | 214 |
|
|
2017
Q4 | $4.44M | Sell |
75,704
-705
| -0.9% | -$41.4K | 0.04% | 334 |
|
|
2017
Q3 | $3.58M | Sell |
76,409
-1,383
| -2% | -$64.7K | 0.03% | 415 |
|
|
2017
Q2 | $2.8M | Sell |
77,792
-549
| -0.7% | -$19.8K | 0.02% | 491 |
|
|
2017
Q1 | $2.41M | Hold |
78,341
| – | – | 0.02% | 541 |
|
|
2016
Q4 | $2.62M | Sell |
78,341
-12,675
| -14% | -$425K | 0.02% | 542 |
|
|
2016
Q3 | $2.42M | Hold |
91,016
| – | – | 0.02% | 603 |
|
|
2016
Q2 | $2.01M | Sell |
91,016
-4,900
| -5% | -$108K | 0.02% | 632 |
|
|
2016
Q1 | $2.82M | Buy |
95,916
+4,900
| +5% | +$144K | 0.03% | 559 |
|
|
2015
Q4 | $3.01M | Buy |
91,016
+13,503
| +17% | +$446K | 0.03% | 552 |
|
|
2015
Q3 | $2.8M | Hold |
77,513
| – | – | 0.03% | 531 |
|
|
2015
Q2 | $3.49M | Hold |
77,513
| – | – | 0.04% | 478 |
|
|
2015
Q1 | $2.37M | Hold |
77,513
| – | – | 0.03% | 560 |
|
|
2014
Q4 | $3.94M | Buy |
+77,513
| New | +$3.94M | 0.05% | 421 |
|